ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. Using the platform, the Company strives to improve outcomes for CNS cancers, neurodegenerative, genetic and rare diseases.
|HQ||Athens, GA, US||Map|
|Employees (est.) (Jul 2020)||27||(+4%)|
ArunA Bio total Funding
ArunA Bio latest funding size
Time since last funding
|2 years ago|
ArunA Bio investors
|Small Business Innovation Research, Eshelman Ventures|
ArunA Bio has 222 Twitter Followers. The number of followers has increased 1.1% month over month and increased 3.3% quarter over quarter
When was ArunA Bio founded?
ArunA Bio was founded in 2003.
Who are ArunA Bio key executives?
ArunA Bio's key executives are Mark Sirgo, C. William Griffin and Steven Stice.
How many employees does ArunA Bio have?
ArunA Bio has 27 employees.
Who are ArunA Bio competitors?
Competitors of ArunA Bio include Codiak Biosciences, Quentis Therapeutics and TCR CURE Biopharma.
Where is ArunA Bio headquarters?
ArunA Bio headquarters is located at 425 River Rd, Athens.
Where are ArunA Bio offices?
ArunA Bio has an office in Athens.
How many offices does ArunA Bio have?
ArunA Bio has 2 offices.
Receive alerts for 300+ data fields across thousands of companies